These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12608469)

  • 41. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis.
    Miyanishi K; Takayama T; Ohi M; Hayashi T; Nobuoka A; Nakajima T; Takimoto R; Kogawa K; Kato J; Sakamaki S; Niitsu Y
    Gastroenterology; 2001 Oct; 121(4):865-74. PubMed ID: 11606500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
    Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
    Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations.
    Hörkkö TT; Tuppurainen K; George SM; Jernvall P; Karttunen TJ; Mäkinen MJ
    Int J Cancer; 2006 Apr; 118(7):1653-9. PubMed ID: 16231318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients].
    Amosenko FA; Korchagina EL; Matveeva TI; Vaganov IuE; Vlasov SB; Poltavets NV; Veselov VV; Gar'kavtseva RF; Poliakov AV
    Genetika; 2010 May; 46(5):700-8. PubMed ID: 20583607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.
    Selcukbiricik F; Erdamar S; Ozkurt CU; Molinas Mandel N; Demirelli F; Ozguroglu M; Tural D; Buyukunal E; Serdengecti S
    J BUON; 2013; 18(1):116-23. PubMed ID: 23613396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
    Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
    Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
    Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
    Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
    J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.
    Tobi M; Luo FC; Ronai Z
    J Natl Cancer Inst; 1994 Jul; 86(13):1007-10. PubMed ID: 8007010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
    Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
    Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report.
    Kovalchuk O; Naumnik W; Serwicka A; Chyczewska E; Niklinski J; Chyczewski L
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():70-2. PubMed ID: 11820633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Farnesyltransferase inhibitors: potential role in the treatment of cancer.
    Cox AD
    Drugs; 2001; 61(6):723-32. PubMed ID: 11398905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Farnesyltransferase activity and mRNA expression in human skin basal cell carcinomas.
    Khan SG; Dummer R; Siddiqui J; Bickers DR; Agarwal R; Mukhtar H
    Biochem Biophys Res Commun; 1996 Mar; 220(3):795-801. PubMed ID: 8607844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
    Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. K-ras mutations and prognosis in large-bowel carcinomas.
    Andersen SN; Løvig T; Breivik J; Lund E; Gaudernack G; Meling GI; Rognum TO
    Scand J Gastroenterol; 1997 Jan; 32(1):62-9. PubMed ID: 9018769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
    Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
    Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.